~~<i id='8719362CF6'><strike id='8719362CF6'><tt id='8719362CF6'><pre id='8719362CF6'></pre></tt></strike></i>~~

Home» leisure time» focus

focus

author：entertainment 2025-10-06 18:57:38 Page View：39845

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: CAR
Next article： Activists slam private health insurers over coverage restrictions

explore

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Pushing for an NIH office for post

MarkWilson/NewsmakersWhentheWhiteHousereleasedPresidentBiden’s2025budgetrequeststhisweek,fundingforb

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

1:29AmemberofMomsforLibertyprotestsagainstmandatoryfacemasksforstudentsduringtheCOVID-19pandemicatam